|
Market Closed -
Nasdaq
02:30:00 21/01/2026 am IST
|
5-day change
|
1st Jan Change
|
|
22.74 USD
|
+1.07%
|
 |
+8.70%
|
+15.14%
|
|
14/01 |
UBS Adjusts Alignment Healthcare Price Target to $21 From $18, Maintains Neutral Rating
|
MT
| |
31/25/31 |
UBS Adjusts Alignment Healthcare Price Target to $18 From $17, Maintains Neutral Rating
|
MT
| |
25/25/25 |
Alignment Healthcare's Strong Medicare Advantage Model Supports Better Results, Higher Savings, KeyBanc Says
|
MT
| |
25/25/25 |
KeyBanc Upgrades Alignment Healthcare to Overweight From Sector Weight, Price Target is $21
|
MT
| |
31/25/31 |
Alignment Healthcare Q2 revenue beats estimates; co raises annual outlook
|
RE
| |
02/25/02 |
UBS Adjusts Alignment Healthcare Price Target to $17 From $16, Maintains Neutral Rating
|
MT
| |
28/25/28 |
UBS Adjusts Price Target on Alignment Healthcare to $16 From $12, Keeps Neutral Rating
|
MT
| |
03/24/03 |
Stephens Upgrades Alignment Healthcare to Overweight From Equalweight, Price Target is $17
|
MT
| |
30/24/30 |
UBS Adjusts Price Target on Alignment Healthcare to $12 From $9, Maintains Neutral Rating
|
MT
| |
11/24/11 |
KeyBanc Initiates Alignment Healthcare at Sector Weight
|
MT
| |
02/24/02 |
UBS Adjusts Price Target on Alignment Healthcare to $9 From $6.50, Maintains Neutral Rating
|
MT
| |
30/24/30 |
BofA Securities Upgrades Alignment Healthcare to Buy From Neutral, Raises Price Target to $11 From $7.75
|
MT
| |
30/24/30 |
Baird Initiates Alignment Healthcare With Outperform Rating, $10 Price Target
|
MT
| |
08/24/08 |
Piper Sandler Upgrades Alignment Healthcare to Overweight From Neutral
|
MT
| |
03/24/03 |
UBS Adjusts Price Target on Alignment Healthcare to $6.50 From $8.50, Maintains Neutral Rating
|
MT
| |
23/24/23 |
Stifel Adjusts Alignment Healthcare's Price Target to $9 From $11, Maintains Buy Rating
|
MT
| |
06/24/06 |
Piper Sandler Downgrades Alignment Healthcare to Neutral From Overweight, Adjusts Price Target to $6 From $12
|
MT
| |
28/24/28 |
UBS Adjusts Alignment Healthcare Price Target to $8.50 From $9, Maintains Neutral Rating
|
MT
| |
24/24/24 |
Stifel Starts Coverage on Alignment Healthcare with Buy Rating, $11 Price Target
|
MT
| |
09/24/09 |
Stephens Adjusts Price Target on Alignment Healthcare to $10.50 From $9, Keeps Equalweight Rating
|
MT
| |
21/23/21 |
UBS Adjusts Alignment Healthcare Price Target to $9 From $6.50, Maintains Neutral Rating
|
MT
| |
02/23/02 |
BofA Securities Downgrades Alignment Healthcare to Neutral From Buy
|
MT
| |
16/23/16 |
Raymond James Upgrades Alignment Healthcare to Strong Buy From Outperform, Adjusts Price Target to $10 From $9
|
MT
| |
12/23/12 |
Stephens Initiates Coverage on Alignment Healthcare with Equalweight Rating, $9 Price Target
|
MT
| |
30/23/30 |
Morgan Stanley Adjusts Alignment Healthcare's Price Target to $12 From $19, Keeps Overweight Rating
|
MT
|
No results for this search Select your edition All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition
| 
